1st Edition
Anabolic Treatments for Osteoporosis
280 Pages
2 B/W Illustrations
by
CRC Press
288 Pages
by
CRC Press
Also available as eBook on:
Osteoporosis, a growing epidemic among women in North America, Europe, and Japan, is a painful, costly disease that has presented a treatment challenge to healthcare professionals. Until recently, therapies have focused on agents that slow bone resorption, and have had only limited success at increasing bone mass.
Osteoporoses: Their Nature and Therapeutic Targets, H.M. Frost
Osteoporosis - Mechanisms and Models, L. Mosekilde
PTH: Skeletal Effects in the Ovariectomized Rat Model for Postmenopausal Bone Loss, T.J. Wronski and M. Li
Parathyroid Hormone: The Clinical Experience and Prospects, A.B. Hodsman, L.J. Fraher, and P.H. Watson
Adenylyl Cyclase-Activating Anabolic Agents: Parathyroid Hormone and Prostaglandins E, J.F. Whitfield, P. Morley, R. Langille, and G. Willick
Bone Formation May Be Uncoupled from Resorption, as Demonstrated by a New Class of hPTHrP-(1-34) Analogues in Both Rapid and Slow Turnover Models of Osteopenia, B.H. Vickery, Z. Avnur, G.I. McRae, R. Waters, E. Hill, and J.L. Krstenansky
Commercial Exploitation of Parathyroid Hormone Therapy for the Treatment of Postmenopausal Osteoporosis, G. Marchand
The Insulin-Like Growth Factors: Potential Anabolic Agents for the Skeleton, A. Johansson and C.J. Rosen
Osteogenic Actions of Fluoride: Its Therapeutic Use for Established Osteoporosis, K.-H. W. Lau, K. Åkesson, C.R. Libanati, and D.J. Baylink
Index
Osteoporosis - Mechanisms and Models, L. Mosekilde
PTH: Skeletal Effects in the Ovariectomized Rat Model for Postmenopausal Bone Loss, T.J. Wronski and M. Li
Parathyroid Hormone: The Clinical Experience and Prospects, A.B. Hodsman, L.J. Fraher, and P.H. Watson
Adenylyl Cyclase-Activating Anabolic Agents: Parathyroid Hormone and Prostaglandins E, J.F. Whitfield, P. Morley, R. Langille, and G. Willick
Bone Formation May Be Uncoupled from Resorption, as Demonstrated by a New Class of hPTHrP-(1-34) Analogues in Both Rapid and Slow Turnover Models of Osteopenia, B.H. Vickery, Z. Avnur, G.I. McRae, R. Waters, E. Hill, and J.L. Krstenansky
Commercial Exploitation of Parathyroid Hormone Therapy for the Treatment of Postmenopausal Osteoporosis, G. Marchand
The Insulin-Like Growth Factors: Potential Anabolic Agents for the Skeleton, A. Johansson and C.J. Rosen
Osteogenic Actions of Fluoride: Its Therapeutic Use for Established Osteoporosis, K.-H. W. Lau, K. Åkesson, C.R. Libanati, and D.J. Baylink
Index
Biography
James F. Whitfield, Paul Morley
